Team:BIT/HP4
Integrated Human Practice
What Can We Solve？
This year, the final goal of iGEM_Bit team is to provide the potential versatility, precision, and affordability of JACOB—essentially a representation of modularized biomarker detections—to ordinary communities. Biomarkers can reflect the user’s risk of corresponding cancer to.So as to warn the real patients to go to the hospital earlier.Less money,but higher cure rate.
Where is our market？
Diagnostic Market”,so how about IVD? JACOB falls in the category of in vitro diagnostic devices, particularly serum biomarker detection. Diagnosis market is characterized by inelastic demanding and steady growth. According to the International Trade Administration, medical device market is forecasted to grow $20 Billion per year after 2017, along with constant growth of population. For United States solely, In Vitro diagnostic devices made up 14.7% of total medical device export in 2015, while keep increasing, currently ranked 4th among all categories. Such market is advantageous to the commercialization of JACOB.
What determined characteristics of JACOB?
a. Four Aspects: Facilis ipsum reprehenderit nemo molestias. Aut cum mollitia reprehenderit. Eos cumque dicta adipisci architecto culpa amet.
Hire Us!
